Alphaform AG (AFRMF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAlphaform AG (AFRMF) trades at $0.0001. Alphaform AG specializes in generative 3D layering technologies and medical product manufacturing across Germany, Europe, Turkey, and the United States. Sector: Industrials.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for AFRMF: AFRMF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Alphaform AG (AFRMF) Industrial Operations Profile
Alphaform AG is a German-based specialist in generative 3D layering technologies and medical product manufacturing, operating across Europe, Turkey, and the US. The company provides consulting, prototyping, and small-series production in plastics and metals, serving critical sectors including automotive, aerospace, and medical technology with its advanced manufacturing solutions.
What Is the Investment Thesis for AFRMF?
Alphaform AG operates in the high-growth niche of generative 3D layering and specialized medical product manufacturing, offering exposure to advanced industrial processes and the resilient healthcare sector. Despite reporting a market capitalization of $0.00 billion and a negative profit margin of -10.3%, the company demonstrates a robust gross margin of 64.7%, indicating strong pricing power for its specialized services and efficient cost management at the production level. Key value drivers include its diversified service offerings across AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting, catering to critical industries like automotive and medical technology. Growth catalysts are anticipated from the increasing adoption of additive manufacturing technologies across industrial sectors and the consistent demand for specialized medical implants. However, the company faces significant risks, including its current unprofitability, the extremely high negative Beta of -6306.06, and the inherent challenges associated with trading on the OTC market, which typically involves lower liquidity and transparency. Investors would need to assess the sustainability of its gross margins and potential pathways to profitability, alongside the unique market dynamics suggested by its financial metrics.
Based on FMP financials and quantitative analysis
AFRMF Key Highlights
Market Capitalization: $0.00 billion, indicating a micro-cap status or potentially limited public float.
- Gross Margin: 64.7%, reflecting strong profitability at the production level for its specialized manufacturing and consulting services.
- Profit Margin: -10.3%, highlighting the company's current unprofitability despite its high gross margins.
- Employee Base: 258 employees, indicating a specialized workforce dedicated to advanced manufacturing and client solutions.
- Beta: -6306.06, an exceptionally high negative beta, suggesting extreme volatility and an inverse relationship with broader market movements, which may warrant further investigation into its trading characteristics.
Who Are AFRMF's Competitors?
AFRMF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| HCAI Hauchen AI Parking Management Technology Holding Co., Ltd. | $0.50 | -0.89% | — | |
| JCSE JE Cleantech Holdings Limited | $1.40 | -1.76% | $7.46M | 84 5-pillar |
| WFF WF Holding Limited Ordinary Shares | $2.32 | -3.53% | $11.7M | 31 5-pillar |
| GTEC Greenland Technologies Holding Corporation | $0.82 | +1.22% | $21.5M | 83 5-pillar |
| CVV CVD Equipment Corporation | $4.32 | -0.23% | $30.1M | 49 5-pillar |
| BWEN Broadwind, Inc. | $4.20 | -1.18% | $99.5M | 33 5-pillar |
| HURC Hurco Companies, Inc. | $22.61 | +1.41% | $144M | 55 5-pillar |
| TAYD Taylor Devices, Inc. | $58.30 | +6.07% | $177M | 74 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AFRMF's Key Strengths?
Specialized expertise in generative 3D layering technologies for plastics and metals.
- Established presence in the high-value medical device manufacturing sector.
- Diverse service offerings including consulting, prototyping, and small-series production.
- Broad customer base across multiple industrial and medical technology sectors.
- Strong gross margin of 64.7% indicates efficient production or pricing power.
What Are AFRMF's Weaknesses?
Negative profit margin of -10.3% indicates current unprofitability.
- Market capitalization of $0.00 billion suggests extremely limited market presence or liquidity.
- Extremely high negative Beta of -6306.06 implies unusual market behavior and high volatility.
- OTC Other listing with unknown disclosure status presents significant transparency and liquidity challenges.
- Reliance on specialized, often niche, manufacturing processes may limit scalability without significant investment.
What Are the Key Risks for AFRMF?
Financial-distress signal — its Altman Z-Score of 0.07 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-38.4%) — the business is not currently generating profit on shareholder capital.
- Sustained negative profit margin of -10.3% indicates a challenge in converting gross profit into net income.
- Extremely low market capitalization of $0.00 billion and OTC Other listing pose significant liquidity and transparency risks for investors.
- Intense competition within the additive manufacturing and contract manufacturing sectors could pressure pricing and market share.
- Economic downturns or industry-specific slowdowns in key client sectors like automotive or aerospace could reduce demand for Alphaform AG's services.
- Regulatory changes or delays in approvals within the highly regulated medical technology sector could impact its medical product segment.
What Threats Does AFRMF Face?
- Intense competition from other additive manufacturing service providers and traditional manufacturers.
- Economic downturns impacting industrial, automotive, and aerospace sectors, reducing demand for prototyping and specialized parts.
- Rapid technological obsolescence in additive manufacturing requiring continuous investment in R&D.
- Stringent regulatory environment and compliance costs in the medical technology sector.
- High liquidity risk and potential for price manipulation due to OTC Other listing and low market cap.
What Are AFRMF's Competitive Advantages?
- Specialized expertise in generative 3D layering technologies across both plastics and metals.
- Presence in the high-barrier-to-entry medical device manufacturing sector with specific implants.
- Comprehensive service offering from consulting to prototyping and small-series production.
- Diversified client base across multiple high-tech industrial sectors, reducing reliance on a single industry.
- Geographic reach across Germany, rest of Europe, Turkey, and the United States.
What Does AFRMF Do?
Founded in 1995 and headquartered in Feldkirchen, Germany, Alphaform AG has evolved into a specialized provider of generative 3D layering technologies and a manufacturer of medical products. The company's operational footprint extends across Germany, the rest of Europe, Turkey, and the United States, catering to a diverse client base. Alphaform AG structures its operations into three primary segments: AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting. Within these segments, the company delivers a comprehensive suite of services that begins with consulting on product development processes, encompassing content and planning, and extends to the manufacturing of virtual or real prototypes and small series of products. Its manufacturing capabilities include producing prototype parts and models from resin and plastic powder, as well as plastic and metal parts specifically for the demanding automotive industry. Beyond industrial applications, Alphaform AG holds a significant presence in the medical technology sector, manufacturing critical medical implants such as hip joint implants, cranial trauma plates, knee implants, and specialized clips for tendon operations. The company's extensive client roster spans across various high-value sectors, including automotive, machinery, plant and commercial vehicle construction, aerospace and aviation, tool making, medical technology, household appliances, and telecommunications. Additionally, it serves electro-technical companies, universities, and research institutions, underscoring its broad applicability and technical expertise in advanced manufacturing.
What Products and Services Does AFRMF Offer?
- Provides generative 3D layering technologies for industrial applications.
- Manufactures medical products, including various implants and surgical clips.
- Offers consulting services for product development process content and planning.
- Produces virtual or real prototypes and small series of products.
- Manufactures prototype parts and models from resin and plastic powder.
- Produces plastic and metal parts specifically for the automotive industry.
- Operates through AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting segments.
- Serves a wide range of sectors including automotive, aerospace, medical technology, and telecommunications.
How Does AFRMF Make Money?
- Generates revenue from providing specialized generative 3D layering and additive manufacturing services.
- Earns income from the sale of manufactured medical implants and components.
- Receives fees for consulting services related to product development and prototyping.
- Monetizes its expertise in producing prototypes and small series for various industrial clients.
- Leverages its multi-segment approach (plastics, metals, precision casting) to cater to diverse client needs.
What Industry Does AFRMF Operate In?
Alphaform AG operates within the Industrials sector, specifically in Industrial Machinery, with a strong focus on additive manufacturing (3D layering) and specialized medical product fabrication. The global additive manufacturing market is experiencing significant expansion, driven by demand for rapid prototyping, customized production, and complex geometries across diverse industries like automotive, aerospace, and medical technology. Alphaform AG's positioning across AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting allows it to capture value from these trends. Its dual focus on industrial applications and the highly regulated medical device market provides a diversified revenue stream. The competitive landscape includes specialized additive manufacturing firms and traditional contract manufacturers, with Alphaform AG differentiating itself through its comprehensive service offering, from consulting to final product delivery, and its expertise in high-value medical implants.
Who Are AFRMF's Key Customers?
- Automotive industry for plastic and metal parts, prototypes, and rapid tooling.
- Medical technology sector for implants (hip, cranial, knee) and surgical clips.
- Machinery, plant, and commercial vehicle construction companies.
- Aerospace and aviation industries requiring advanced prototypes and components.
- Tool making, household appliances, telecommunications, electro-technical companies, universities, and research institutions.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Alphaform AG operates in the Industrial - Machinery industry within the Industrials sector. It is headquartered in Feldkirchen, DE. The company is led by CEO Hanns-Dieter Aberle. AFRMF has traded publicly since 2014.
Key Financial Metrics
Return on equity for Alphaform AG stands at -38.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -15.5%, showing how much profit it generates from its asset base. A current ratio of 1.18 indicates the company holds enough short-term assets to cover its near-term obligations.
Financial Health
Alphaform AG's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.07 places it in the distress zone, a signal of elevated financial risk.
AFRMF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
AFRMF Latest News
No recent news available for AFRMF.
AFRMF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AFRMF.
Price Targets
Wall Street price target analysis for AFRMF.
AFRMF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AFRMF; grades run from A+ (80-100) to F (below 30).
Leadership: Hanns-Dieter Aberle
Managing Director
Hanns-Dieter Aberle serves as a key leader at Alphaform AG, overseeing the company's operations and strategic direction. His role involves managing a workforce of 258 employees across the company's various segments and geographic regions.
Track Record: Under Hanns-Dieter Aberle's leadership, Alphaform AG continues to operate its diverse segments, including AM Plastics/Modelling, AM Metal/Rapid Tooling, and Precision Casting. His tenure involves guiding the company in providing generative 3D layering technologies and manufacturing medical products for a broad international client base. Managing 258 employees, his strategic decisions likely focus on maintaining operational efficiency, fostering innovation in additive manufacturing, and navigating the complexities of serving both industrial and highly regulated medical technology markets.
AFRMF OTC Market Information
Alphaform AG trades on the OTC Other tier, which is the lowest and most speculative tier of the OTC market. This tier is for companies that do not meet the disclosure or financial standards of higher tiers like OTCQX or OTCQB, or for companies that are delinquent in their filings. Securities in this tier often have limited public information, making comprehensive due diligence challenging. Investors should be aware that companies on the OTC Other tier are subject to minimal reporting requirements, which can significantly increase investment risk compared to stocks listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Lack of Transparency: Unknown disclosure status means limited or no access to financial statements and operational updates.
- Low Liquidity: Extremely low market capitalization and OTC Other listing suggest minimal trading volume, making it hard to buy or sell shares.
- Price Volatility: Shares on the OTC Other tier can be highly volatile due to limited information and low trading activity.
- Limited Regulatory Oversight: Companies on this tier are subject to fewer regulatory requirements compared to major exchanges.
- Potential for Fraud: The lack of transparency and oversight can increase the risk of fraudulent activities or misleading information.
- Verify any available financial statements or reports from independent sources, if possible.
- Research any news or press releases from the company, though these may be infrequent or unaudited.
- Thoroughly understand the company's business model, products, and market position based on limited information.
- Assess the management team's background and track record, seeking information outside of official filings.
- Review any regulatory filings that might exist, even if not through OTC Markets Group.
- Consider the extremely low market capitalization and its implications for investment size and exit strategy.
- Evaluate the company's operational footprint and client base for signs of legitimate business activity.
- Established in 1995, indicating a long operational history.
- Diversified service offerings in generative 3D layering and medical product manufacturing.
- Specific product lines, such as hip joint implants and cranial trauma plates, suggest specialized expertise.
- Operations in multiple geographic regions including Germany, rest of Europe, Turkey, and the United States.
- Serves a wide range of established industrial and medical technology sectors.
Common Questions About AFRMF (Industrials)
What are the key financial metrics investors watch for AFRMF?
For Alphaform AG, investors would closely monitor several key financial metrics given its unique profile. The reported gross margin of 64.7% is significant, indicating strong pricing power or efficient production for its specialized services.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Market capitalization of $0.00B is highly unusual and suggests either an extremely small market float, a data anomaly, or a company with negligible public trading value. All analysis is based on this reported figure.
- The extremely high negative Beta value (-6306.06) is also highly unusual and may indicate a data error or highly specific, inverse market dynamics that are not typical. Analysis proceeds with this reported figure.
- The 'Unknown' disclosure status for the OTC listing severely limits the depth of financial analysis and increases inherent investment risk.